A Chinese-led international collaboration has unveiled Asia's first decade-long roadmap for building synthetic cells, a landmark blueprint that charts a systematic path toward creating artificial life from scratch.
Spearheaded by Liu Chenli, director of the Shenzhen Institute of Advanced Technology (SIAT) at the Chinese Academy of Sciences, the initiative brought together over 100 laboratories across six Asian countries: China, Japan, the Republic of Korea, Singapore, Malaysia and Thailand. The roadmap was published on Tuesday in the journal Nature Biotechnology.
This marks the first time Asia has produced a systematic development blueprint around the concept of an artificial single-cell life form, setting new scientific benchmarks for synthetic cell research over the next decade.
"By bringing together scientists from the six Asian countries, we launched the SynCell Asia Initiative, forming a collaborative effort to tackle the pioneering fundamental scientific challenge of artificially synthesizing unicellular organisms," said Liu.
Unlike genetically modified cells, which tweak existing organisms, synthetic cells assemble life from biological macromolecules, such as phospholipids, proteins, and DNA, to create a basic single-cell system that functions like a living organism. One of the aims of the initiative is to answer a fundamental question that has intrigued humanity for centuries: can life be forged from non-living matter?
The roadmap identifies core challenges for scientists: maintaining continuous metabolism or "metabolic continuity"; ensuring the self-renewal of protein factories, known as "autonomous ribosome regeneration"; and solving issues related to modular design and complex timing coordination.
To tackle these obstacles, the blueprint proposes an AI-powered "bio-foundry" operating under a central factory with “distributed workstations”. While a central platform at SIAT will prepare standardized parts and chassis, research teams across Asia will collaborate on design, synthesis and testing.
The blueprint sets forth a two-phase strategy for the next decade. The first phase targets the creation of a "proto-cell" featuring a stable phospholipid vesicle structure. The second phase aims to build an "auto-cell" capable of autonomous ribosome regeneration, meaning the cell can produce its own protein-making machinery internally, and complete more than 10 continuous, coordinated growth-division cycles. This transition would advance synthetic cells from mere operation to genuine self-replication, representing a giant leap forward in the field.
China-led initiative unveils Asia's first 10-year roadmap for synthetic cell research
